期刊文献+

THE USEFULNESS OF ^(99)Tc-PMT DELAYED HEPATOBILIARY IMAGING IN THE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMA 被引量:1

THE USEFULNESS OF ^(99)Tc-PMT DELAYED HEPATOBILIARY IMAGING IN THE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMA
下载PDF
导出
摘要 This investigation was aimed to assess the usefulness of delayed hepalobillary Imaging in the diagnosis of small hepatocellular carcinoma (HCC). Sixty-two patients with this hepatic cancer were Included in the study. 56 males and 6 females, with a mean age of 50. 6 yr. (32 - 72 years old). All patients were performed by surgery, verified histologically, and these tumors were smaller than 5 cm. Liver scans were performed 5 minutes, 2 hours and 5 hours after the administration of radlopharmaceutices. In 31 of the 62 patients (50%), the tumor exhibited equal radioactivity uptake or greater radioactivity uptake than the surrounding liver in delayed imaging. And the sensitivity was 33. 3% (2/6), 41.2% (7/17), 60.0% (9/15) and 54.2% (13/24) In the tumor size was ≤2 cm, 2-3cm, 3-4 cm and 4 - 5 cm, respectively. The smallest mass to be detected was only 1. 2 cm. The uptake of radiopharmaceutic was nonsignificantly related to serum AFP level and hepatic cirrhosis (P>0. 05). These results show that 99-Tc-PMT delayed hepatobiliary imaging can be useful in the diagnosis of small hepatocellular carcinoma. This investigation was aimed to assess the usefulness of delayed hepalobillary Imaging in the diagnosis of small hepatocellular carcinoma (HCC). Sixty-two patients with this hepatic cancer were Included in the study. 56 males and 6 females, with a mean age of 50. 6 yr. (32 - 72 years old). All patients were performed by surgery, verified histologically, and these tumors were smaller than 5 cm. Liver scans were performed 5 minutes, 2 hours and 5 hours after the administration of radlopharmaceutices. In 31 of the 62 patients (50%), the tumor exhibited equal radioactivity uptake or greater radioactivity uptake than the surrounding liver in delayed imaging. And the sensitivity was 33. 3% (2/6), 41.2% (7/17), 60.0% (9/15) and 54.2% (13/24) In the tumor size was ≤2 cm, 2-3cm, 3-4 cm and 4 - 5 cm, respectively. The smallest mass to be detected was only 1. 2 cm. The uptake of radiopharmaceutic was nonsignificantly related to serum AFP level and hepatic cirrhosis (P>0. 05). These results show that 99-Tc-PMT delayed hepatobiliary imaging can be useful in the diagnosis of small hepatocellular carcinoma.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1992年第2期64-69,共6页 中国癌症研究(英文版)
  • 相关文献

参考文献9

  • 1Victor W. Lee,Jerome H. Shapiro.Specific diagnosis of hepatoma using 99mTc-HIDA and other radionuclides[J]. European Journal of Nuclear Medicine . 1983 (5)
  • 2Yeh SH,et al.99m</sup>Tc-HIDA liver scintigraphy for diagnosing hepatoma&amp;sid=The Journal of Nuclear Medicine&amp;aufirst=Yeh SH');&#xA; ">Sensitivity of <sup>99m</sup>Tc-HIDA liver scintigraphy for diagnosing hepatoma. The Journal of Nuclear Medicine . 1981
  • 3Wagner HN.Nuclear medicine in the 1990s: The chalienge of change. The Journal of Nuclear Medicine . 1985
  • 4Utz JA,et al.99m</sup>Tc-pyidoxylidene glutamate&amp;sid=The Journal of Nuclear Medicine&amp;aufirst=Utz JA');&#xA; ">Hapatoma visualization with <sup>99m</sup>Tc-pyidoxylidene glutamate. The Journal of Nuclear Medicine . 1980
  • 5Cannon JR,et al.99m</sup>Tc-PIPIDA in pulmonary metastases from a hepatoma&amp;sid=Clinical Nuclear Medicine&amp;aufirst=Cannon JR');&#xA; ">Uptake of <sup>99m</sup>Tc-PIPIDA in pulmonary metastases from a hepatoma. Clinical Nuclear Medicine . 1980
  • 6Hasegawa Y,et al.Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging. Cancer . 1986
  • 7Tang ZY.Subclinical hepatocellular carcinoma. . 1985
  • 8Okuda K.Early recognition of hepatocellular carcinoma. Hepatology . 1986
  • 9Ueno K,Haseda Y.99m</sup>Tc-pyridoxyliden isoleucine by a hepatoma&amp;sid=Clinical Nuclear Medicine&amp;aufirst=Ueno K');&#xA; ">Concentration and clearance of <sup>99m</sup>Tc-pyridoxyliden isoleucine by a hepatoma. Clinical Nuclear Medicine . 1980

同被引文献1

引证文献1

  • 1Bing-Hui Yang, Jing-Lin Xia, Li-Wen Huang, Zhao-You Tang, Ming-Shan Chen, Jin-Qing Li, An-Min Liang, Qin-Guo Mo, Hui-Shan Lu, Chao-Liu Dai, Lu-Nan Yan, Zhi-Jian Yu, Rong-Sheng Rao, Le-Qun Li, Zhi-Xiong Su, Zhuang-Wei Fang Shanghai, China Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai 200032, China,Tumor Hospital, Zhongshan University, Guangzhou 510000, China Tumor Hospital, Guangxi Medical Universi- ty, Nanning 530000, China,Xiehe Hospital, Fujian Medical University, Fuzhou 350000, China,Second Hos- pital, Chinese Medical University, Shenyang 110000, China ,Huaxi Hospital, Sichuan University, Chengdu 610041, China ,Hospital Affiliated to Nantong Medical University, Nantong 226000 , China,Second Hospital, Jiangxi Medical University, Nanchang 330000 , China ,First Hospital Affiliated to Guangxi Medical University, Nanning 530000 , China ,People’s Hospital of Hainan Province, Haikou 570000, China.Changed clinical aspects of primary liver cancer in China during the past 30 years[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):194-198. 被引量:20

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部